Brief: Nkgen Biotech Size Of Board Temporarily Reduced From Five To Two Directors
03/10/2024 23:05
Oct 3 (Reuters) - Nkgen Biotech Inc NKGN.O :
* NKGEN BIOTECH: SIZE OF BOARD TEMPORARILY REDUCED FROM FIVE
TO
TWO DIRECTORS
* NKGEN BIOTECH: SIZE OF EACH COMMITTEE IS TEMPORARILY
REDUCED
FROM THREE TO ONE MEMBER
Source text for Eikon: ID:n0001213900-24-085116
Further company coverage: NKGN.O
Recent news on Nkgen Biotech
See all newsBrief: Nkgen Biotech Expands Clinical Trial Site Network For Alzheimer’S Disease Program Across US
Brief: NKgen Biotech And Hekabio Enter Into Strategic Partnership
Brief: Nkgen Biotech Announces International And U.S. Expansion Of Phase 1/2A Troculeucel Alzheimer’S Trial
Brief: Nkgen Biotech Announces Administration Of First Dose Of Troculeucel To Stroke Patient Under FDA-Cleared Compassionate Use Program
Brief: NKGen Biotech Announces Administration Of First Dose Of Troculeucel To Frontotemporal Dementia Patient Under FDA-Cleared Compassionate Use Program